• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[洛桑心血管代谢队列研究:糖尿病与血脂异常,总有新发现!]

[CoLaus: diabetes and dyslipidemia, there is always something new!].

作者信息

Vollenweider P, Vaucher J, Bastardot F, Schmid R, Vidal P Marques, Waeber G

机构信息

Service de médecine interne, CHUV, 1011 Lausanne

出版信息

Rev Med Suisse. 2011 Nov 2;7(315):2122, 2124-6.

PMID:22187780
Abstract

Cardiovascular diseases remain the first cause of mortality in our country. They are associated with well known risk factors such as diabetes and dyslipidemia. Herein we summarize main results of the CoLaus study regarding, first the prevalence and characteristics of the treatment of these risk factors. Then we present recent discoveries of new genetic determinants associated with these risk factors. Finally, we discuss whether this knowledge changes our current clinical management of our patients.

摘要

心血管疾病仍然是我国的首要死因。它们与糖尿病和血脂异常等众所周知的风险因素相关。在此,我们总结了CoLaus研究的主要结果,首先是这些风险因素治疗的患病率和特征。然后,我们介绍了与这些风险因素相关的新遗传决定因素的最新发现。最后,我们讨论了这些知识是否会改变我们目前对患者的临床管理。

相似文献

1
[CoLaus: diabetes and dyslipidemia, there is always something new!].[洛桑心血管代谢队列研究:糖尿病与血脂异常,总有新发现!]
Rev Med Suisse. 2011 Nov 2;7(315):2122, 2124-6.
2
Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.法国全科医疗中接受降脂治疗患者的混合性血脂异常:一项观察性研究。
Clin Ther. 2007 Aug;29(8):1671-81. doi: 10.1016/j.clinthera.2007.08.003.
3
[Health examination survey of the Lausanne population: first results of the CoLaus study].[洛桑人群健康检查调查:CoLaus研究的初步结果]
Rev Med Suisse. 2006 Nov 8;2(86):2528-30, 2532-3.
4
[What CoLaus has brought to public health].[洛桑心血管疾病队列研究(CoLaus)对公共卫生的贡献]
Rev Med Suisse. 2011 Nov 2;7(315):2118, 2120-1.
5
[Implementation of clinical guidelines in general practice. The effect of journal audit and continuing education for the treatment of cardiovascular risk factors in patients with and without type 2 diabetes].[临床指南在全科医疗中的实施。针对伴有和不伴有2型糖尿病患者心血管危险因素治疗的期刊审核及继续教育的效果]
Ugeskr Laeger. 2006 Apr 24;168(17):1640-5.
6
Adherence to a Mediterranean-type diet and reduced prevalence of clustered cardiovascular risk factors in a cohort of 3,204 high-risk patients.在3204名高危患者队列中,坚持地中海式饮食与聚集性心血管危险因素患病率降低之间的关系
Eur J Cardiovasc Prev Rehabil. 2008 Oct;15(5):589-93. doi: 10.1097/HJR.0b013e328308ba61.
7
[Therapeutic approach to dyslipidemia and goal achievement in a Spanish population with type 2 diabetes without cardiovascular disease].[西班牙2型糖尿病无心血管疾病人群血脂异常的治疗方法及目标达成情况]
Endocrinol Nutr. 2011 Jun-Jul;58(6):283-90. doi: 10.1016/j.endonu.2011.03.005.
8
[When should we start the treatment of the cardiovascular risk factors].我们应该在何时开始治疗心血管危险因素
An R Acad Nac Med (Madr). 2008;125(1):125-36; discussion 136-44.
9
Mixed dyslipidemia, metabolic syndrome, diabetes mellitus, and cardiovascular disease: clinical implications.混合性血脂异常、代谢综合征、糖尿病和心血管疾病:临床意义。
Am J Cardiol. 2008 Dec 22;102(12A):5L-9L. doi: 10.1016/j.amjcard.2008.09.067.
10
Prevalence of dyslipidemia and its associated factors among Jordanian adults.约旦成年人血脂异常的患病率及其相关因素。
J Clin Lipidol. 2010 Jan-Feb;4(1):53-8. doi: 10.1016/j.jacl.2009.12.004. Epub 2009 Dec 22.